ConductScience.org, home

Paper39588561

Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor-Positive Triple-Negative Breast Cancer by Inhibiting c-MYC-mediated Tumorigenesis.

Xie X and 9 others. Mol Cancer Ther, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor-Positive Triple-Negative Breast Cancer by Inhibiting c-MYC-mediated Tumorigenesis. Papers, record 39588561. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39588561

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor-Positive Triple-Negative Breast Cancer by Inhibiting c-MYC-mediated Tumorigenesis.
PubMed
Journal
Mol Cancer Ther
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-12-05
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Triple Negative Breast NeoplasmsMajor topic
PhenylthiohydantoinMajor topic
Receptors, AndrogenMajor topic
Proto-Oncogene Proteins c-mycMajor topic
Cyclin-Dependent KinasesMajor topic
Humans
Benzamides
Nitriles
Animals
Female
Mice
Cell Line, Tumor
Xenograft Model Antitumor Assays
Cyclin-Dependent Kinase-Activating Kinase
Cell Proliferation
Drug Synergism
Gene Expression Regulation, Neoplastic
Carcinogenesis

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA016672NCI NIH HHSUnited StatesP30CA016672PubMed and NIHNIH RePORTER
CA016672-29Center for Cancer Research (CCR)PubMedPubMed
P30 CA054174NCI NIH HHSUnited StatesP30CA054174PubMed and NIHNIH RePORTER
P30 CA071789NCI NIH HHSUnited StatesP30CA071789PubMed and NIHNIH RePORTER
P30CA016672Center for Cancer Research (CCR)P30CA016672PubMed and NIHNIH RePORTER
APR-18-006Breast Cancer Research Foundation (BCRF)PubMedPubMed

Download CSV of grants

References59

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118511414Site-specific androgen receptor serine phosphorylation linked to epidermal growth factor-dependent growth of castration-recurrent prostate cancer.J Biol Chem2008https://conductscience.org/library/papers/18511414PubMed
232650419Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer.Cancers (Basel)2020https://conductscience.org/library/papers/32650419PubMed
331466944CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation.Cancer Discov2019https://conductscience.org/library/papers/31466944PubMed
432988969A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast Cancer.Clin Cancer Res2020https://conductscience.org/library/papers/32988969PubMed
523965901Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer.Clin Cancer Res2013https://conductscience.org/library/papers/23965901PubMed
623010705Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor-expressing triple-negative breast carcinoma.Am J Clin Pathol2012https://conductscience.org/library/papers/23010705PubMed
737076563The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer.Br J Cancer2023https://conductscience.org/library/papers/37076563PubMed
821552212Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.Mod Pathol2011https://conductscience.org/library/papers/21552212PubMed
929883487Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features.PLoS One2018https://conductscience.org/library/papers/29883487PubMed
1025693131The Mediator complex: a central integrator of transcription.Nat Rev Mol Cell Biol2015https://conductscience.org/library/papers/25693131PubMed
1128144231Non-Genomic Actions of the Androgen Receptor in Prostate Cancer.Front Endocrinol (Lausanne)2017https://conductscience.org/library/papers/28144231PubMed
1223634260The CDK Network: Linking Cycles of Cell Division and Gene Expression.Genes Cancer2012https://conductscience.org/library/papers/23634260PubMed
1336975020A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022).Expert Opin Ther Pat2023https://conductscience.org/library/papers/36975020PubMed
1425512207Targeting heat shock proteins in metastatic castration-resistant prostate cancer.Nat Rev Urol2015https://conductscience.org/library/papers/25512207PubMed
1533384381Using biochemistry and biophysics to extinguish androgen receptor signaling in prostate cancer.J Biol Chem2021https://conductscience.org/library/papers/33384381PubMed
1623031358Expression of androgen receptors in triple negative breast carcinomas.Acta Histochem2013https://conductscience.org/library/papers/23031358PubMed
1718507821Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors.BMC Cancer2008https://conductscience.org/library/papers/18507821PubMed
1829340907Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer.Horm Cancer2018https://conductscience.org/library/papers/29340907PubMed
1926201402Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.Horm Cancer2015https://conductscience.org/library/papers/26201402PubMed
2034754128Treatment landscape of triple-negative breast cancer - expanded options, evolving needs.Nat Rev Clin Oncol2022https://conductscience.org/library/papers/34754128PubMed

See all 59 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42278564Beyond Molecular Classification in Metastatic Triple-Negative Breast Cancer: Toward Subtype-Guided Precision Oncology.Int J Mol Sci2026https://conductscience.org/library/papers/42278564PubMed
41986659ATR inhibition potentiates the antitumor efficacy of HER3-DXd in HER3-positive/HR-positive breast cancer by increasing DNA damage.Br J Cancer2026https://conductscience.org/library/papers/41986659PubMed
41968987Integrative multi-omic analysis identified ERBB2 mutations and senescence-driven immune suppression as dual therapeutic targets in LAR triple-negative breast cancer.Cancer Biol Med2026https://conductscience.org/library/papers/41968987PubMed
40897935Advances of androgen receptor in triple-negative breast cancer: from molecular mechanisms to clinical applications.Discov Oncol2025https://conductscience.org/library/papers/40897935PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AR367PubTator's text mininghttps://conductscience.org/library/genes/367NCBI Gene
CDK71022PubTator's text mininghttps://conductscience.org/library/genes/1022NCBI Gene
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene
PTPRF5792PubTator's text mininghttps://conductscience.org/library/genes/5792NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39588561

GET https://conductscience.org/api/papers/v1/39588561/references?page=2